October 2009

Agile Sciences and SePRO Corporation announce an agreement to develop Agile Sciences' technology for use in Turf and Ornamental applications. News release.

September 2009

Agile Sciences enters technology development and commercialization agreement with SePRO Corporation to apply Agile Sciences' proprietary compound to Aquatics applications. News release.

August 2009

Agile Sciences' co-founders discuss Agile's Technology on Radio in Vivo. Link to podcast.

July 2009

Agile Sciences is awarded a $150,000 NSF STTR Grant to apply Agile's anti-biofilm technology toward membrane filtration. News release.

More News...

Agile Sciences founders John Cavanagh and Christian Melander analyze the results of anti-biofilm screening tests.

The co-founders of Agile Sciences have developed compounds that can disperse colonies of bacteria called biofilms. These compounds have applications in the areas of medicine, agriculture, and industry.

Biofilms that form in the human body are up to ten thousand times more resistant to antibiotics and immune systems than free-floating bacteria, making them very difficult to treat medically. In agriculture, every year billions of dollars of crops are lost due to the formation of biofilms. Industrial needs for effective biofilm dispersion include surface coatings and cleansing products.

Agile Sciences' technology addresses problems associated with biofilm formation through the use of proprietary non-toxic organic compounds.